DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Health Companies"


25 mentions found


☆ FTC bans online mental health company BetterHelp from sharing user data for targeted ads, as federal crackdowns on info misuse intensify
  + stars: | 2023-03-02 | by ( Aaron Mcdade | ) www.businessinsider.com   time to read: +4 min
The FTC announced a settlement with BetterHelp over allegations of sharing user data with third parties. BetterHelp will be banned from sharing the data with outside parties for advertising, and pay $7.8 million in partial refunds. Users who signed up from August 2017 through 2020 may have had their data improperly shared, per the FTC. He continued: "Instead, BetterHelp betrayed consumers' most personal health information for profit. The company was similarly banned from sharing the health information of its users with advertisers, and agreed to pay a $1.5 million fine.
☆ Inflation takes a back seat to earnings next week as stocks look to bounce back
  + stars: | 2023-02-24 | by ( Matthew J. Belvedere | ) www.cnbc.com   time to read: +7 min
The latest Fed projection for the so-called terminal rate — the level where the rate hikes stop — was just over 5%. Before this past week, those intraday levels hadn't been seen since November 2022. ET: ISM Services Looking back January's hot reading on core PCE on Friday was the most influential economic number of the past week. In Club earnings this past week, Nvidia (NVDA) was certainly the highlight. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
☆ Bausch Health's stock soars on solid quarterly results, but we have concerns about the recovery
  + stars: | 2023-02-23 | by ( Zev Fima | ) www.cnbc.com   time to read: +4 min
Bottom line The Canadian specialty pharmaceuticals company reported solid results for the fourth quarter, along with favorable forward guidance. Bausch management on Thursday did not offer additional information, other than to reiterate its confidence in the strength of the company's patents. Bausch Health previously started the separation process via an initial public offering of Bausch + Lomb in May 2022. Results at the diversified products division — which includes neurology pharmaceutical products, generics and dentistry products — were hampered by generic competition. Notably, as Bausch Health owns most of Bausch + Lomb, the latter's financials still appear on Thursday's results.
☆ The Club is selling shares in 23 holdings to fund this year’s charitable donation
  + stars: | 2023-02-21 | by ( Jeff Marks Jim Cramer | Jeff Marks | Jim Cramer | ) www.cnbc.com   time to read: +3 min
As a reminder, every year Jim Cramer's Charitable Trust distributes all dividend income and realized capital gains to qualified publicly supported charitable organizations. Our total contribution this year is $326,951, and this brings our total donation since the Club's inception to approximately $4.1 million. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.
☆ Top 10 things the Club is watching in the stock market Wednesday: Retail sales up, stocks dip, Airbnb soars
  + stars: | 2023-02-15 | by ( Jeff Marks | ) www.cnbc.com   time to read: +4 min
Retail sales for January came in higher than expected. Remember, retail sales are not adjusted for inflation, which of course remains elevated but growing at a slower rate in recent months. Earnings per share (EPS) of 48 cents versus 25 cents expected. Kraft Heinz (KHC) EPS beats: 85 cents versus 78 cents expected. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
☆ As ChatGPT mania takes hold, here's how companies beyond tech are using A.I.
  + stars: | 2023-02-08 | by ( Samantha Subin | ) www.cnbc.com   time to read: +7 min
AI's been in use for years, of course, helping companies improve products, efficiency and their business models. Media conglomerate Comcast (the parent of CNBC) is harnessing AI to improve expenses and innovate within high-speed broadband, while Stanley Black & Decker mentioned it's using AI to help customers better measure the hardening of concrete. Here's how some of the biggest companies outside of technology are utilizing AI to improve their businesses: Healthcare companies bet on AI One of the biggest beneficiaries of the latest AI trends might be healthcare companies. Some health companies also view machine learning and AI as tools to assist in areas with doctor shortages or fewer resources. Minneapolis-based utility Xcel Energy said it's using AI technology to improve efficiency at its plants and move from "reactive to proactive maintenance," said Brian Van Abel, Xcel's chief financial officer.
☆ Here’s our February rapid-fire update on all 34 stocks in Jim Cramer’s Investing Club portfolio
  + stars: | 2023-02-05 | by ( Matthew J. Belvedere | ) www.cnbc.com   time to read: +12 min
Here's a rapid-fire update on all 34 stocks in Jim Cramer's Charitable Trust, the holdings we manage in the CNBC Investing Club. J & J is a good stock to get into ahead of the impending split into two companies: consumer brands and pharma/medical technology. The company reported a good quarter and guidance, while fundamentals are solid ahead of the split. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
☆ The 15 billion-dollar healthcare startups facing a make-or-break year in 2023
  + stars: | 2023-02-02 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +2 min
Billion-dollar healthcare startups could take a hit to their valuations if they fundraise this year. These are the 15 highest-valued healthcare startups that could be hit by the market contraction. Throughout the year, 85 healthcare companies hit valuations of $1 billion or higher worldwide, according to CB Insights. Of the 15 startups with the highest valuations in healthcare, 11 companies haven't announced funding rounds since 2021. Here are the 15 highest-valued healthcare startups to watch.
☆ GoodRx pays $1.5 million to settle health privacy allegations
  + stars: | 2023-02-01 | by ( ) www.reuters.com   time to read: +1 min
WASHINGTON, Feb 1 (Reuters) - U.S. healthcare firm GoodRx Holdings (GDRX.O) has agreed to pay $1.5 million to settle allegations that it failed to notify customers that it shared personal health information with Alphabet's (GOOGL.O) Google, Meta's (META.O) Facebook and others, the Federal Trade Commission said on Wednesday. Under the terms of the settlement, GoodRx will be barred from sharing user health data with other companies to use for advertising. "Digital health companies and mobile apps should not cash in on consumer’s extremely sensitive and personally identifiable health information," said Samuel Levine, director of the FTC's Bureau of Consumer Protection, in a statement. The settlement is the first under the FTC's Health Breach Notification Rule, the agency said. GoodRx promised users it would never share health information with advertisers but gave information to Google, Facebook, Criteo and others, the agency said in their complaint.
☆ The generative AI boom is bringing San Francisco’s tech scene roaring back to life
  + stars: | 2023-01-31 | by ( Diamond Naga Siu | ) www.businessinsider.com   time to read: +5 min
Techies fled from San Francisco during the pandemic, and its resurgence stalled for a while. It's just south of Japantown, mere blocks from San Francisco City Hall, and north of the Mission District. Someone even said it would be "irresponsible" to not work on generative AI in San Francisco. There aren't any skeptics in the space yet, and the majority of generative AI investments land in the Bay Area. Email dsiu@insider.com or tweet @diamondnagasiu) Edited by Matt Weinberger (tweet @gamoid) in San Francisco and Hallam Bullock (tweet @hallam_bullock) in London.
☆ Inside digital health's reckoning, where once-hot startups are suddenly scrambling for cash
  + stars: | 2023-01-31 | by ( Blake Dodge | Rebecca Torrence | ) www.businessinsider.com   time to read: +11 min
Analysts and CEOs told Insider more than half of healthcare startups will shut down by 2024. Healthcare startups looking to stay afloat have been laying off employees left and right. The online pharmacy Truepill burned through its cash as it struggled to fill prescriptions efficiently, two former employees told Insider. A spokesperson for Truepill told Insider in an email that the company's burn rate was in line with its projections. Courtesy NOCDWhile the broader economic pressures will hurt many startups that can't raise, it may help others, experts told Insider.
☆ Cramer's lightning round: L3Harris Technologies is still a buy
  + stars: | 2023-01-27 | by ( Krystal Hur | ) www.cnbc.com   time to read: +1 min
Loading chart...Dutch Bros Inc : "You've got to wait [to buy], because we still see wage pressure." Loading chart...Farfetch Ltd : "I don't know FTCH. Loading chart...Bausch Health Companies Inc : "We've got that on what I would regard as being a retainer basis. We simply don't know what to do. Disclaimer: Cramer's Charitable Trust owns shares of Bausch Health Companies and Nvidia.
☆ Here's our January rapid-fire update on all 34 stocks in Cramer’s Charitable trust portfolio
  + stars: | 2023-01-19 | by ( Kevin Stankiewicz | ) www.cnbc.com   time to read: +11 min
Here's a rapid-fire update on every stock in the CNBC Investing Club portfolio. As much as we'd like to maintain a bigger position in this roughly $472 stock, we're refraining from violating our cost basis of $291.52. ( See here for a full list of the stocks in Jim Cramer's Charitable Trust portfolio.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
☆ DEA Pressed ADHD-Drug Makers About Impact of Telehealth Firms on Surging Demand
  + stars: | 2022-12-31 | by ( Rolfe Winkler | ) www.wsj.com   time to read: 1 min
The Drug Enforcement Administration told makers of medication for attention-deficit hyperactivity disorder that it was concerned that “aggressive marketing practices” by companies including telehealth providers could be driving excessive prescriptions, according to a letter from the agency. While the letter doesn’t cite specific companies, it reflects the DEA’s concerns about marketing efforts for ADHD treatment by telehealth companies such as Cerebral Inc. and Done Global Inc., whose prescribing practices the agency has been investigating. The DEA said in December that it wouldn’t allow any increase in 2023 production of pharmaceutical ingredients that go into Adderall and other stimulants used to treat ADHD. The letter, reviewed by The Wall Street Journal, was sent to drugmakers over the summer but hasn’t previously been reported.
☆ These stocks were our best and worst performers in the fourth quarter
  + stars: | 2022-12-30 | by ( Jeff Marks | ) www.cnbc.com   time to read: +10 min
What made the fourth quarter stand out from the first three of the year? Here's a snapshot of the best and worst performers in the Investing Club's 33-stock portfolio for the fourth quarter, starting with our top 4 performers. Worst performers Turning to what didn't work in the fourth quarter, the worst performer for the club was Amazon (AMZN), which fell 27.6% in the quarter. Revenues declined year-over-year for the second quarter in a row, but that was mostly anticipated by the market. The fourth worst performer was Walt Disney (DIS), which fell 10.8% in the quarter It all unraveled for Disney after it reported a much weaker-than-expected fiscal fourth quarter in November.
☆ A top healthcare banker predicts some digital-health startups will be able to go public in 2023
  + stars: | 2022-12-28 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +4 min
SVB Securities' Jon Swope thinks some digital-health startups will IPO in the second half of 2023. In 2021, 15 US-based digital-health companies went public via IPO, according to Rock Health. Only one digital-health company has gone public this year: Akili Interactive Labs, which went public in August in a SPAC deal. Seeing the writing on the wall, digital-health companies like Komodo Health that sought to IPO this year are now putting those plans on hold. But SVB Securities' Jon Swope said he thinks the IPO market will reopen for certain digital-health companies in the second half of 2023.
☆ A top private equity investor predicts Big Tech will acquire a health company to defend against the recession, and 3 other M&A drivers in 2023
  + stars: | 2022-12-28 | by ( Blake Dodge | ) www.businessinsider.com   time to read: +4 min
He predicted a wave of consolidation in digital health due to the economic downturn. He also said a big tech or retail company may be interested in a healthcare purchase. The market volatility has made it harder to predict healthcare startups' financial futures and valuations, critical components of M&A, he told Insider. As for what type of healthcare companies tech firms will actually acquire, Gregory said it could be those that sell health records, primary care, or Medicare Advantage plans. Missy Krasner, a top digital health investor, echoed this prediction to Insider, saying that Alphabet, Salesforce, or Amazon could move to acquire a company that has patient health records.
☆ Misleading Ads Fueled Rapid Growth of Online Mental Health Companies
  + stars: | 2022-12-27 | by ( Khadeeja Safdar | Andrea Fuller | ) www.wsj.com   time to read: 1 min
In an advertisement on Facebook and Instagram, a middle-aged man holding a dumbbell says testosterone “literally changed my life,” restoring his energy and happiness. What the October ad from telehealth startup Hone Health doesn’t say is that the unidentified man is an actor who has never used the prescription drug. It doesn’t mention that testosterone is approved by the Food and Drug Administration only for men with specific disorders and that among its risks are heart attacks and stroke.
☆ Here’s our third-quarter earnings report card for all the stocks in our portfolio
  + stars: | 2022-12-27 | by ( Zev Fima | ) www.cnbc.com   time to read: +17 min
Third-quarter earnings season is finally behind us — and like the prior quarter, results were solid overall compared to analyst forecasts. Danaher (DHR) reported sales and earnings beats on the back of better-than-expected results in all three segments of the health technology company. While U.S. customer traffic was down in the quarter, management noted that it improved sequentially and improved throughout the quarter. Still the luxury hotel and casino company reported solid third-quarter results boosted by its U.S. properties. Amazon (AMZN) reported results that were disappointing, to say the least, and compounded by guidance that was even worse.
☆ How Cerebral went from a hyped $4.8 billion mental-health startup to fighting for its survival
  + stars: | 2022-12-22 | by ( Blake Dodge | ) www.businessinsider.com   time to read: +10 min
It called itself the fastest-growing mental-health company. Some Cerebral clinicians told Insider they were uncomfortable treating the patients assigned to them and felt their licenses were at risk. In the past few years, highly funded startups have tried to disrupt mental-health care and struggled. Cerebral's next steps will dictate its future, and its story could influence what's ahead for online mental-health care. A former Cerebral provider told Insider the ban was frustrating because many patients who were improving on the drugs lost access to care at Cerebral.
☆ The Failed Promise of Online Mental-Health Treatment
  + stars: | 2022-12-18 | by ( Rolfe Winkler | ) www.wsj.com   time to read: 1 min
Remote treatment of mental-health problems surged in the pandemic, as in-person treatment became difficult while pandemic-driven isolation increased anxiety and depression. Digital mental-health companies plunged in, promising to provide millions with access to high-quality care by video, phone, and messaging.
☆ Here's our November rapid-fire update on all 33 stocks in Cramer's Charitable trust portfolio
  + stars: | 2022-12-15 | by ( Kevin Stankiewicz | ) www.cnbc.com   time to read: +9 min
Here's a rapid-fire update on every stock in the CNBC Investing Club portfolio. Estee Lauder (EL) — New Club members who want to start a position in the cosmetics giant could do so at these levels. We'd advise Club members do so the same, even if we still like the company's defensive nature. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.
☆ A new wave of companies is making testosterone easily available online. The authors of a recent study say there could be risks to patients.
  + stars: | 2022-12-09 | by ( Sarah Braner | ) www.businessinsider.com   time to read: +6 min
A recent study reviewed seven companies that prescribe testosterone therapy online. These companies say that they make treatment more accessible for people who already suspect they have low testosterone. A new study shows that DTC companies do not all follow medical guidelinesThe new study encourages patients looking to get testosterone therapy online to educate themselves before taking the leap. The study found that six out of seven of the companies tested offered testosterone therapy to the shopper. The study was not meant to evaluate companies prescribing testosterone for gender affirming hormone therapy, which is a different process than testosterone replacement therapy.
☆ Buzzy startups failed to fix mental-health care. Now their mistakes are fueling the space's next generation.
  + stars: | 2022-12-01 | by ( Blake Dodge | ) www.businessinsider.com   time to read: +13 min
In the past two years, highly funded startups have tried to disrupt mental-health care. The startups said they wanted to help solve the industry's biggest problems: Mental-health care is too expensive, and there isn't enough of it to go around. Talkspace's priority is now its division that sells mental-health care to employers, which pay recurring fees for employee access. Startups tackling more serious mental-health conditions are working with health plansThere's also a rising crop of mental-health companies tackling the costliest mental-health conditions, something the direct-to-consumer firms tend to shy away from. About half of Bicycle's patients pay with their insurance, a number he's looking to increase.
☆ Telehealth Companies Lobby to Extend Pandemic-Era Rules
  + stars: | 2022-11-25 | by ( Liz Essley Whyte | Rolfe Winkler | Brianna Abbott | ) www.wsj.com   time to read: +1 min
More than 100 groups have asked the DEA to create a registry of providers allowed to continue prescribing controlled substances online. Health startups and medical associations are lobbying for permanent permission to prescribe controlled substances remotely, part of a broader debate over the future of telehealth services that boomed during the pandemic. The push comes after some online startups faced scrutiny from lawmakers and pharmacies over their prescription practices. To maintain pandemic-era telehealth practices, more than 100 groups asked the Drug Enforcement Administration this month to create a registry of providers allowed to prescribe drugs online for conditions including opioid addiction. That would protect their operations when the Biden administration ends the Covid-19 public-health emergency, during which restrictions on telehealth have been relaxed.
<< prev 3 next >>
Total: 25